Antiplatelet agent for the prevention of late hepatic vascular complications in living donor liver transplant dominant population

CONCLUSION: We recommend against antiplatelet therapy for more than 1 year in clinically stable LT recipients.PMID:38641537 | DOI:10.1016/j.asjsur.2024.04.002

Source: Asian Journal of Surgery - April 19, 2024 Category: Surgery Authors: Deok-Gie Kim Sung Hwa Kim Jun Young Lee Jae Geun Lee Source Type: research